Article: Keppra XR(TM) Offers Convenient Dosing For People With Partial Onset Seizures.

-- Online survey shows people living with epilepsy often miss a dose of their antiepileptic drug

-- UCB continues to build on the company's commitment to patients living with epilepsy through the launch of Keppra XR(TM) (levetiracetam) extended-release tablets

-- Keppra XR(TM) is one of many upcoming milestones in the UCB Epilepsy Franchise

ATLANTA, Nov. 5 /PRNewswire/ -- press release, regulated information: UCB announced today that Keppra XR(TM) offers convenient dosing for people with epilepsy. Keppra XR(TM) was approved by the U.S. Food and Drug Administration (FDA) in September 2008 for use as an add-on to other antiepileptic treatments ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!